XMBD:LSE:LSE-Xtrackers - MSCI Brazil UCITS ETF (USD)

ETF | Others |

Last Closing

USD 39.33

Change

+0.15 (+0.38)%

Market Cap

N/A

Volume

272.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-24 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

-0.50 (-0.22%)

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

+3.06 (+2.24%)

USD 618.20B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

+0.12 (+0.67%)

USD 562.96B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

+0.06 (+0.46%)

USD 562.96B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

+0.30 (+0.48%)

USD 266.08B
0QZO:LSE 0QZO

+0.30 (+0.27%)

USD 258.54B
PRJU:LSE Amundi Index Solutions - Amund..

+0.22 (+0.75%)

USD 211.57B
0QZ3:LSE Qualcomm Inc.

-0.21 (-0.13%)

USD 202.26B
0R24:LSE Intel Corp.

+0.24 (+1.20%)

USD 196.14B

ETFs Containing XMBD:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -29.77% 4% F 12% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -29.77% 4% F 12% F
Trailing 12 Months  
Capital Gain -28.37% 4% F 13% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -28.37% 4% F 12% F
Trailing 5 Years  
Capital Gain -27.10% 10% F 25% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -27.10% 9% A- 24% F
Average Annual (5 Year Horizon)  
Capital Gain 8.03% 56% F 62% D
Dividend Return 8.03% 56% F 61% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 19.47% 36% F 52% F
Risk Adjusted Return 41.25% 49% F 65% D
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.